These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36357048)

  • 1. Adding a Biologic to Asthma Therapy: The Role of Adherence in Selecting the Right Patient.
    Stempel DA; Szefler SJ
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2949-2950. PubMed ID: 36357048
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric Severe Asthma in the Era of Biologic Treatments.
    Teague WG
    Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Asthma Biologics: Implications for Patient Selection, Step Therapy, and Outcomes.
    Maddux JT; Inselman JW; Jeffery MM; Lam RW; Shah ND; Rank MA
    Chest; 2021 Mar; 159(3):924-932. PubMed ID: 33558205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in Allergy: Are Biologic Treatment Responses in Severe Asthma the Same in Adults and Children?
    Gaberino CL; Bacharier LB; Jackson DJ
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2673-2682. PubMed ID: 37517797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New guidelines and new therapy options in severe asthma].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
    [No Abstract]   [Full Text] [Related]  

  • 8. The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Rosas-Salazar C; Bacharier LB
    Ann Allergy Asthma Immunol; 2024 Jan; 132(1):7-8. PubMed ID: 38123282
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of Real-World Escalation to Biologics in US Patients With Asthma.
    Bender B; Oppenheimer J; George M; Brown R; Patel A; Hill T; Boe A; Mayen Herrera E; Dotiwala Z; Casciano J; Bernstein JA
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2941-2948. PubMed ID: 35931363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of choosing the correct biologic for the correct asthma patient.
    Sriaroon P; Casale TB
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):385-386. PubMed ID: 30290891
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring Biologic Therapy in Asthma Using Functional Imaging.
    Fain SB; Comellas AP
    Chest; 2023 Jul; 164(1):3-5. PubMed ID: 37423697
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologic medications for asthma.
    Bridgeman MB; Dalal KS
    Nursing; 2023 May; 53(5):53. PubMed ID: 37074284
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine.
    Mustafa SS; Patrawala S; Khurana S
    Curr Opin Pulm Med; 2022 May; 28(3):266-273. PubMed ID: 35131991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biologic therapies for the management of pediatric asthma.
    Lovinsky-Desir S
    Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma: a disease of variability.
    Congleton J
    Drug Ther Bull; 2021 Apr; 59(4):50. PubMed ID: 33766921
    [No Abstract]   [Full Text] [Related]  

  • 16. To stop or not to stop an asthma biologic, that is the question.
    Philipenko BS; Davis B; Cockcroft DW
    Ann Allergy Asthma Immunol; 2024 Sep; 133(3):236-237. PubMed ID: 39179302
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry.
    Cheng IH; Yong SB; Cheng-Chung Wei J
    J Allergy Clin Immunol Pract; 2024 Feb; 12(2):535-536. PubMed ID: 38336402
    [No Abstract]   [Full Text] [Related]  

  • 18. Are we entering an era of combined biologic use for severe asthma?
    Arslan B; Şeker S; Yılmaz İ
    Tuberk Toraks; 2022 Dec; 70(4):403-404. PubMed ID: 36537099
    [No Abstract]   [Full Text] [Related]  

  • 19. Can asthma biologics change the course of disease and induce drug-free remission?
    Cohn L
    J Allergy Clin Immunol; 2022 Jul; 150(1):59-61. PubMed ID: 35447228
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting the right biologic for your patients with severe asthma.
    Manka LA; Wechsler ME
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):406-413. PubMed ID: 30056149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.